Related Experiment Video
Updated: May 29, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Acute Lung Injury in Immunocompromised Patients
Brogan Barry1, Dane Stewart1, Kyle R Brownback2
1Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, MailStop 3007, Kansas City, KS 66160, USA.
Acute lung injury (ALI) is a growing concern in immunocompromised patients. Early recognition of infection as a common cause is crucial for timely diagnosis and management.
Area of Science:
- Pulmonology
- Immunology
- Critical Care Medicine
Background:
- Acute lung injury (ALI) is a severe complication in immunocompromised individuals.
- The incidence of ALI in this population is increasing due to advances in medical care allowing longer survival.
- Immunocompromised patients represent a vulnerable group susceptible to severe respiratory distress.
Purpose of the Study:
- To highlight the increasing incidence and significance of acute lung injury in immunocompromised patients.
- To emphasize the importance of recognizing potential causes, particularly infection, for earlier diagnosis.
- To outline current management strategies for acute lung injury in this patient cohort.
Main Methods:
- This abstract is based on a review of current medical literature and clinical understanding.
- It synthesizes information regarding the causes, diagnosis, and management of ALI in immunocompromised hosts.
- No specific experimental methods were employed; it is a conceptual overview.
Main Results:
- Infection is identified as a frequent and critical cause of acute lung injury in immunocompromised patients.
- Awareness of potential etiologies facilitates earlier detection and diagnosis of ALI.
- The diagnostic process for ALI in this group must include infectious causes.
Conclusions:
- Acute lung injury poses a significant threat to immunocompromised patients, with rising incidence.
- Prompt identification of infectious agents is paramount for effective management of ALI.
- Supportive care, including mechanical ventilation and potential pharmacological interventions, forms the cornerstone of ALI treatment.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia III: Complications and Assessment
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

